NYSE : ARDT
Ardent Health, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 12.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.73B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.70B |
| Enterprise Value | 3.24B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 141.05M |
| Shares Outstanding | 141.05M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 1.72% |
| Owned by Institutions (%) | 22.29% |
| Float | 21.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 21.79 |
| Forward PE | 10.37 |
| PS Ratio | 0.26 |
| Forward PS | 0.26 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 4.42 |
| P/FCF Ratio | 5.57 |
| P/OCF Ratio | 3.30 |
| PEG Ratio | 2.82 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 41.41 |
| EV / Sales | 0.51 |
| EV / EBITDA | 7.67 |
| EV / EBIT | 12.56 |
| EV / FCF | 10.63 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.10 |
| Quick Ratio | 1.49 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | 7.44 |
| Interest Coverage | 5.05 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.96% |
| Return on Assets (ROA) | 3.13% |
| Return on Invested Capital (ROIC) | 6.25% |
| Return on Capital Employed (ROCE) | 5.99% |
| Weighted Average Cost of Capital (WACC) | 4.55% |
| Revenue Per Employee | $254,204 |
| Profits Per Employee | $3,104 |
| Employee Count | 25,200 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 22.74 |
Taxes
| Measure | Value |
|---|
| Income Tax | 39.32M |
| Effective Tax Rate | 18.91% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -19.85% |
| 50-Day Moving Average | 11.16 |
| 200-Day Moving Average | 9.98 |
| Relative Strength Index (RSI) | 57.65 |
| Average Volume (20 Days) | 483,572 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.75M |
| Short Previous Month | 4.58M |
| Short % of Shares Out | 2.66% |
| Short % of Float | 17.24% |
| Short Ratio (days to cover) | 7.62 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 6.41B |
| Gross Profit | 3.74B |
| Operating Income | 257.90M |
| Pretax Income | 207.96M |
| Net Income | 78.23M |
| EBITDA | 422.42M |
| EBIT | 257.90M |
| Earnings Per Share (EPS) | $0.55 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 724.48M |
| Total Debt | 2.27B |
| Net Cash | -1.54B |
| Net Cash Per Share | -$10.94 |
| Equity (Book Value) | 1.74B |
| Book Value Per Share | 9.52 |
| Working Capital | 1.08B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 514.32M |
| Capital Expenditures | -209.57M |
| Depreciation & Amortization | 164.52M |
| Net Borrowing | -7.05M |
| Free Cash Flow | 304.76M |
| FCF Per Share | $2.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 58.38% |
| Operating Margin | 4.03% |
| Pretax Margin | 3.25% |
| Profit Margin | 1.22% |
| EBITDA Margin | 6.59% |
| EBIT Margin | 4.03% |
| FCF Margin | 4.76% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | 4.59% |
| FCF Yield | 17.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.67 |
| Price Target Difference | 5.32% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 3.59% |
| EPS Growth Forecast (3Y) | -2.53% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.03 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |